ArticleInternational journal of cancer2019

A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors.

Colin Weekes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.